We serve DIMETHYL THIO-TOLUENE DIAMINE (DMTDA) CAS:106264-79-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
DIMETHYL THIO-TOLUENE DIAMINE (DMTDA)

Synonyms：
ETHACURE
DADMT
2,4-Diamino-3,5-dimethylthiotoluene
3,5-Dimethylthio-2,4-toluenediamine
Ethacure 300
 
Molecular Formula: C9H14N2S2
Molecular Weight:  214.35100
 
Appearance: light yellow transparent liquid    
density (g/cm320 C): 1.21
Amine value (mgKOH/g):536    
Cps viscosity (20 C): 690
Content: ≤ 95%    
water: ≤ 0.1%
 
Purpose： DMTDA is a new type of polyurethane elastomer curing agent, of which there are two isomers of 2,4- and 2,6- two DMTDA two amine mixture (about 77~80/17~20), compared with the commonly used MOCA, room temperature is low viscosity liquid, suitable for low temperature operation. The use of low chemical equivalent.
Packing： The net weight of 1200 kg / 200KG galvanized steel, 20 tons of IBC, /ISOTANK.
 
The company focuses on R&D and sales of phosphate flame retardant, plasticizer, stabilizer, polyurethane curing, and chain extender. The annual supply of phosphate flame retardant, plasticizer, stabilizer, polyurethane curing, and chain extender products is 8,000 tons.



Contact us for information like DIMETHYL THIO-TOLUENE DIAMINE (DMTDA) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethacure 300 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethacure 300 Use and application,ETHACURE technical grade,usp/ep/jp grade.


Related News: An effective treatment for Alzheimer’s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.(4-methylpyridine)BFCl2 manufacturer They should also not use public transport for a fortnight after returning to Britain.1-(2-Methylpropyl)-4-piperidone supplier In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.4-[4-(acetamidomethyl)phenyloxy]butyric acid vendor In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.We partner with life science companies of all sizes, drawing on over 20 years of industry experience.